MELANOMA (SKIN)
Clinical trials for MELANOMA (SKIN) explained in plain language.
Never miss a new study
Get alerted when new MELANOMA (SKIN) trials appear
Sign up with your email to follow new studies for MELANOMA (SKIN), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Experimental cancer vaccine combo targets tough tumors in early trial
Disease control Recruiting nowThis early-phase study tests a new treatment called PeptiCRAd-1, a virus-based cancer vaccine, combined with the immunotherapy drug pembrolizumab. The goal is to see if this combination is safe and can boost the immune system to fight several types of solid tumors, including mela…
Matched conditions: MELANOMA (SKIN)
Phase: PHASE1 • Sponsor: Valo Therapeutics Oy • Aim: Disease control
Last updated May 16, 2026 22:31 UTC
-
New drug duo aims to tame brain metastases in melanoma patients
Disease control Recruiting nowThis study is testing whether combining two drugs, nivolumab and relatlimab, can help control melanoma that has spread to the brain. About 30 adults with active brain metastases will receive the combination and be monitored for side effects and tumor response. The goal is to impr…
Matched conditions: MELANOMA (SKIN)
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 16, 2026 22:30 UTC
-
New combo aims to revive immune attack in stubborn melanoma
Disease control Recruiting nowThis study tests whether adding a low-dose chemotherapy drug (cyclophosphamide) to an immunotherapy (pembrolizumab) can shrink tumors in people with advanced melanoma that no longer responds to standard immunotherapy. About 14 adults with stage III or IV melanoma will receive the…
Matched conditions: MELANOMA (SKIN)
Phase: PHASE2 • Sponsor: University of California, Irvine • Aim: Disease control
Last updated May 15, 2026 11:56 UTC
-
Exercise and fiber may boost immunotherapy in melanoma patients
Disease control Recruiting nowThis study looks at whether high-intensity exercise and a high-fiber diet are possible and helpful for people with advanced melanoma who are receiving immunotherapy. The goal is to see if these lifestyle changes can improve gut health and immune function. The study will involve 4…
Matched conditions: MELANOMA (SKIN)
Phase: NA • Sponsor: Fred Hutchinson Cancer Center • Aim: Disease control
Last updated May 11, 2026 20:49 UTC
-
New hope for Hard-to-Treat cancers: first human trial launches
Disease control Recruiting nowThis study tests a new drug, HMBD-501, in people with advanced cancers (melanoma, lung, or breast) that have stopped responding to standard treatments. The goal is to find a safe dose and see if it can shrink tumors. About 180 adults will take part in two phases: first to check s…
Matched conditions: MELANOMA (SKIN)
Phase: PHASE1, PHASE2 • Sponsor: Hummingbird Bioscience • Aim: Disease control
Last updated May 04, 2026 16:20 UTC
-
Scientists probe Melanoma's metabolic escape from immunotherapy
Knowledge-focused Recruiting nowThis study looks at why some melanomas stop responding to immunotherapy. Researchers will analyze tumor samples from 20 patients before and after treatment to see how the cancer's energy use changes. The goal is to find new ways to target resistant tumors without harming immune c…
Matched conditions: MELANOMA (SKIN)
Phase: NA • Sponsor: Centre Hospitalier Universitaire de Nice • Aim: Knowledge-focused
Last updated May 14, 2026 12:03 UTC